GW&K Investment Management, LLC - AMNEAL PHARMACEUTICALS INC ownership

AMNEAL PHARMACEUTICALS INC's ticker is AMRX and the CUSIP is 03168L105. A total of 132 filers reported holding AMNEAL PHARMACEUTICALS INC in Q4 2019. The put-call ratio across all filers is 258.75 and the average weighting 0.1%.

Quarter-by-quarter ownership
GW&K Investment Management, LLC ownership history of AMNEAL PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2022$0
-100.0%
81
-79.1%
0.00%
Q3 2019$1,000
-100.0%
387
-100.0%
0.00%
-100.0%
Q1 2019$25,581,000
+4.0%
1,805,274
-0.7%
0.41%
-15.1%
Q4 2018$24,606,000
-45.9%
1,818,637
-11.3%
0.48%
-33.7%
Q3 2018$45,484,000
+41.6%
2,049,765
+4.7%
0.73%
+39.2%
Q2 2018$32,113,0001,956,9060.53%
Other shareholders
AMNEAL PHARMACEUTICALS INC shareholders Q4 2019
NameSharesValueWeighting ↓
Fosun International Ltd 21,521,301$102,442,0009.84%
TPG Group Holdings (SBS) Advisors, Inc. 16,213,367$77,176,0001.36%
Sivik Global Healthcare LLC 600,000$2,856,0000.95%
THB ASSET MANAGEMENT 651,150$3,099,0000.90%
Eversept Partners, LP 886,587$4,220,1540.58%
Spark Investment Management LLC 30,100$143,0000.52%
GLOBEFLEX CAPITAL L P 240,680$1,146,0000.29%
Alambic Investment Management, L.P. 19,493$93,0000.23%
GSA CAPITAL PARTNERS LLP 49,901$238,0000.13%
C M BIDWELL & ASSOCIATES LTD 29,550$141,0000.13%
View complete list of AMNEAL PHARMACEUTICALS INC shareholders